Endostar ( rh‐endostatin ) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Endostar ( rh‐endostatin ) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis

Published:2021-10-21 Issue:23 Volume:12 Page:3208-3215
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Yuan Meng¹^ORCID,Zhai Yirui¹,Men Yu¹²,Wang Jianyang¹,Deng Lei¹^ORCID,Wang Wenqing¹,Bao Yongxing¹,Yang Xu¹,Sun Shuang¹^ORCID,Ma Zeliang¹,Liu Yunsong¹,Wang Jun³^ORCID,Zhu Hui⁴,Hui Zhouguang¹²^ORCID

Affiliation:

1. Department of Radiation Oncology National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

3. Department of Radiation Oncology The Fourth Hospital of Hebei Medical University Shijiazhuang China

4. Department of Radiation Oncology, Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14188

Reference47 articles.

1. Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC

2. Hallmarks of Cancer: The Next Generation

3. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth

4. Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer

5. Endostar combined with chemotherapy versus chemotherapy alone for advanced NSCLCs: a meta‐analysis;Ge W;Asian Pac J Cancer Prev.,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative CT-based radiomic prognostic index to predict the benefit of postoperative radiotherapy in patients with non-small cell lung cancer: a multicenter study;Cancer Imaging;2024-05-13

2. Preoperative CT-Based Radiomic Prognostic Index to Predict the Benefit of Postoperative Radiotherapy in Patients with Non-Small Cell Lung Cancer: A Multicenter Study;2024-03-20

3. A retrospective study on the efficacy and safety of Endostar with chemotherapy in EGFR-TKI-resistant NSCLC;BMC Pulmonary Medicine;2023-11-11

4. Effect of Endostar combined with concurrent chemoradiotherapy in patients with locally advanced cervical cancer;Radiation Medicine and Protection;2023-06

5. Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer;Pharmaceuticals;2023-01-31